previous compound ID: 1909 next compound
InChIKey: RAOCRURYZCVHMG-UHFFFAOYSA-N
SMILES: CCCOC1=CC2=C(C=C1)N=C(N2)NC(=O)OC

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "JW Hanrahan" "J Liao" "J Goepp" "E Matthes" "D Rotin" "GW Carlile" "B Kus" "DY Thomas" "R Robert"
ReferenceID: 92
"EL White" "M Mense" "B Liu" "E Falk Libby" "V Mutyam" "X Xue" "KM Keeling" "MJ Suto" "H Shang" "JR Bostwick" "F Liang" "M Mazur" "JS Hong" "SM Rowe" "M Du" "DM Bedwell" "L Rasmussen"

chemical graph of compound 1909





CID is 4622
synonyms found at PubChem are:
Oxibendazole, 20559-55-1, Oxibendazolo, Loditac, Filaribits Plus, Anthelcide EQ, Oxibendazolum, Oxibendazolum [INN-Latin], Oxibendazolo [INN-Spanish], UNII-022N12KJ0X, EINECS 243-877-7, SKF 30310, SK&F 30310, methyl N-(6-propoxy-1H-benzimidazol-2-yl)carbamate, Methyl 5-propoxy-2-benzimidazolecarbamate, MLS000069646, Methyl 5-n-propoxy-2-benzimidazole carbamate, 022N12KJ0X, C12H15N3O3, N-(2-(5-Propoxybenzimidazolyl)) methyl carbamate, 5-Propoxy-2-benzimidazolecarbamic acid methyl ester, SK&F-30310, NCGC00018238-04, (5-Propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester, SMR000058208, 2-BENZIMIDAZOLECARBAMIC ACID, 5-PROPOXY-, METHYL ESTER, N-(Propoxy-5, benzimidazolyl)-2, carbamate de methyle [French], Carbamic acid, (5-propoxy-1H-benzimidazol-2-yl)-, methyl ester, 5-Propoxy-2-(methoxycarbonylamino)benzimidazole, DSSTox_CID_25625, DSSTox_RID_81010, DSSTox_GSID_45625, Methyl (5-propoxy-1H-benzimidazol-2-yl)carbamate, methyl N-(5-propoxy-1H-benzimidazol-2-yl)carbamate, W-107609, methyl (5-propoxy-1h-benzo[d]imidazol-2-yl)carbamate, oxybendazole, N-(6-propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester, AJ119,(+), CAS-20559-55-1, Oxibendazole [USAN:BAN:INN], Oxibendazole [USAN:INN:BAN], Anthelcide EQ (TN), Oxibendazole, ~98%, Spectrum_001699, AC1L1IKV, methyl 5-n-propoxy-2-benzimidazolecarbamate, Spectrum2_001556, Spectrum3_001951, Spectrum4_000836, Spectrum5_001219, Oxibendazole (USAN/INN), D0B9GM, cid_4622, BSPBio_003551, KBioGR_001411, KBioSS_002179, Oxibendazole, GlaxoSmithKline, MLS006011733, DivK1c_000096, SCHEMBL168101, SPECTRUM1503373, SPBio_001432, CHEMBL1087630, DTXSID5045625, N-(Propoxy-5, benzimidazolyl)-2, carbamate de methyle, BDBM31048, CHEBI:92907, CTK8G2219, HMS500E18, KBio1_000096, KBio2_002179, KBio2_004747, KBio2_007315, KBio3_002864, KS-00000GJR, MolPort-002-817-066, MolPort-003-666-482, NINDS_000096, RAOCRURYZCVHMG-UHFFFAOYSA-N, HMS1922A22, HMS2090F21, HMS2094M09, HMS3713J18, Pharmakon1600-01503373, HY-B0299, ZINC4685859, Tox21_110844, CCG-39334, NSC758459, s1851, STL301145, AKOS015895323, Tox21_110844_1, AC-8714, AN-7054, CCG-220608, CS-2333, DB04910, MCULE-8346438764, NSC-758459, IDI1_000096, NCGC00018238-01, NCGC00018238-02, NCGC00018238-03, NCGC00018238-05, NCGC00018238-06, NCGC00018238-07, NCGC00018238-08, NCGC00018238-09, NCGC00023557-03, NCGC00023557-04, NCGC00023557-05, AS-12166, LS-50577, SC-73431, AB0011434, AB2000332, KB-254690, TL8001701, 5-propoxy-2-(carbomethoxyamino)benzimidazole, FT-0630464, O0499, D05293, methyl 5-propoxy-1H-benzimidazol-2-ylcarbamate, AB00052350-06, AB00052350_07, AB00052350_08, Oxibendazole, VETRANAL(TM), analytical standard, 559O551, A814696, AJ-119/34637010, SR-01000000182, SR-05000002065, I06-0683, SR-01000000182-2, SR-05000002065-1, BRD-K52075715-001-02-6, BRD-K52075715-001-03-4, BRD-K84514357-001-02-9, Methyl (6-propoxy-1H-benzo[d]imidazol-2-yl)carbamate, methyl N-(6-propoxy-1H-1,3-benzodiazol-2-yl)carbamate, Oxibendazole, European Pharmacopoeia (EP) Reference Standard, Carbamic acid, N-(6-propoxy-1H-benzimidazol-2-yl)-, methyl ester